HuGE Literature Finder
Records 1-30
|
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients.
British journal of cancer 2020 Nov . Jácome Alexandre A, Vreeland Timothy J, Johnson Benny, Kawaguchi Yoshikuni, Wei Steven H, Nancy You Y, Vilar Eduardo, Vauthey Jean-Nicolas, Eng Cat |
|
Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Oct . Loree Jonathan M, Dowers Anthony, Tu Dongsheng, Jonker Derek, Edelstein Daniel L, Quinn Hannah, Holtrup Frank, Price Timothy, Zalcberg John R, Moore Malcolm J, Karapetis Christos S, O'Callaghan Chris J, Waring Paul, Kennecke Hagen F, Hamilton Stanley R, Kopetz Sco |
|
Frequency and Coexistence of KRAS, NRAS, BRAF, and PIK3CA Mutations and occurrence of MMR deficiency in Danish Colorectal Cancer Patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2020 Oct . Poulsen Tim Svenstrup, de Oliveira Douglas Vinicius Nogueira Perez, Espersen Maiken Lise Marcker, Klarskov Louise Laurberg, Skovrider-Ruminski Wojciech, Hogdall Estr |
|
Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
International journal of surgical pathology 2020 Oct 1066896920963798. Brcic Iva, Dawson Heather, Gröchenig Hans Peter, Högenauer Christoph, Kashofer Ka |
|
Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies.
Cancer research 2020 Aug . Hidaka Akihisa, Harrison Tabitha A, Cao Yin, Sakoda Lori C, Barfield Richard, Giannakis Marios, Song Mingyang, Phipps Amanda I, Figueiredo Jane C, Zaidi Syed H, Toland Amanda E, Amitay Efrat L, Berndt Sonja I, Borozan Ivan, Chan Andrew T, Gallinger Steven, Gunter Marc J, Guinter Mark A, Harlid Sophia, Hampel Heather, Jenkins Mark A, Lin Yi, Moreno Victor, Newcomb Polly A, Nishihara Reiko, Ogino Shuji, Obón-Santacana Mireia, Parfrey Patrick S, Potter John D, Slattery Martha L, Steinfelder Robert S, Um Caroline Y, Wang Xiaoliang, Woods Michael O, Van Guelpen Bethany, Thibodeau Stephen N, Hoffmeister Michael, Sun Wei, Hsu Li, Buchanan Daniel D, Campbell Peter T, Peters Ulri |
|
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer.
Current problems in cancer 2020 Aug 100637. Prasanna Thiru, Wong Rachel, Price Timothy, Shapiro Jeremy, Tie Jeanne, Wong Hui-Li, Nott Louise, Roder David, Lee Margaret, Kosmider Suzanne, Jalali Azim, Burge Matthew, Padbury Robert, Maddern Guy, Carruthers Scott, Moore James, Sorich Michael, Karapetis Christos S, Gibbs Peter, Yip Desmo |
|
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
European journal of cancer (Oxford, England : 1990) 2020 Aug 137 250-259. Stahler Arndt, Stintzing Sebastian, von Einem Jobst C, Westphalen Christoph B, Heinrich Kathrin, Krämer Nicole, Michl Marlies, Modest Dominik P, von Weikersthal Ludwig Fischer, Decker Thomas, Kiani Alexander, Heintges Tobias, Kahl Christoph, Kullmann Frank, Scheithauer Werner, Moehler Markus, Kaiser Florian, Kirchner Thomas, Jung Andreas, Heinemann Volk |
|
Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2020 Jul 42 (7): 1010428320938492. Wielandt Ana María, Hurtado Claudia, Moreno C Mauricio, Villarroel Cynthia, Castro Magdalena, Estay Marlene, Simian Daniela, Martinez Maripaz, Vial Maria Teresa, Kronberg Udo, López-Köstner Francis |
|
EFFECTIVENESS OF FIRST-LINE CETUXIMAB IN WILD-TYPE RAS METASTATIC COLORECTAL CANCER ACCORDING TO TUMOUR BRAF MUTATION STATUS FROM THE EREBUS COHORT.
British journal of clinical pharmacology 2020 Jul . Rouyer Magali, Francois Eric, Sa Cunha Antonio, Monnereau Alain, Bignon Emmanuelle, Jove Jérémy, Lassalle Régis, Droz-Perroteau Cécile, Moore Nicholas, Noize Pernelle, Fourrier-Réglat Annie, Smith Denis, |
|
Nut and peanut butter intake and the risk of colorectal cancer and its anatomical and molecular subtypes: the Netherlands Cohort Study.
Carcinogenesis 2020 Jul . Nieuwenhuis Lisette, Simons Colinda C J M, Weijenberg Matty P, van den Brandt Piet |
|
Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge.
Cancers 2020 Jun 12 (6): . Junca Audelaure, Tachon Gaëlle, Evrard Camille, Villalva Claire, Frouin Eric, Karayan-Tapon Lucie, Tougeron Dav |
|
Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2020 Jun . García-Alfonso P, García-González G, Gallego I, Peligros M I, Ortega L, Torres Pérez-Solero G, Sandoval C, Muñoz Martin A, Blanco Codesido M, Calvo Ferrándiz A, Martin |
|
Cancers 2020 May 12 (5): . Fennell Lochlan J, Kane Alexandra, Liu Cheng, McKeone Diane, Fernando Winnie, Su Chang, Bond Catherine, Jamieson Saara, Dumenil Troy, Patch Ann-Marie, Kazakoff Stephen H, Pearson John V, Waddell Nicola, Leggett Barbara, Whitehall Vicki L |
|
Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
BMC cancer 2020 May 20 (1): 400. Li Xiaodong, Sun Katherine, Liao Xiaoyan, Gao Haijuan, Zhu Hongfa, Xu Rulia |
|
Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.
Oncology 2020 May 1-8. Dimberg Jan, Andersson Roland E, Haglund Sof |
|
Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
Genes, chromosomes & cancer 2020 May . VaNková Bohuslava, VanEcek Tomáš, Ptáková Nikola, Hájková Veronika, Dušek Martin, Michal Michael, Švajdler Peter, Daum OndRej, Daumová Magdaléna, Michal Michal, Mezencev Roman, Švajdler Mari |
|
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference.
International journal of colorectal disease 2020 May . Roberto Michela, Marchetti Paolo, Arrivi Giulia, Di Pietro Francesca Romana, Cascinu Stefano, Gelsomino Fabio, Caputo Francesco, Cerma Krisida, Ghidini Michele, Ratti Margherita, Pizzo Claudio, Ficorella Corrado, Parisi Alessandro, Cortellini Alessio, Urbano Federica, Calandrella Maria Letizia, Botticelli Andrea, Dell'Aquila Emanuela, Minelli Alessandro, Fulgenzi Claudia, Montori Andrea, Pilozzi Emanuela, Mazzuca Federi |
|
Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.
Translational oncology 2020 May 13 (7): 100786. Taniguchi Hiroya, Uehara Keisuke, Nakayama Goro, Nakayama Hiroshi, Aiba Toshisada, Hattori Norifumi, Kataoka Masato, Nakano Yasuyuki, Kawase Yoshihisa, Okochi Osamu, Matsuoka Hiroshi, Utsunomiya Setsuo, Sakamoto Eiji, Mori Yoshinori, Umeda Shinichi, Shikano Toshio, Komori Koji, Tajika Masahiro, Kadowaki Shigenori, Muro Kei, Yatabe Yasus |
|
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2020 May . García-Alfonso P, García-Carbonero R, García-Foncillas J, Pérez-Segura P, Salazar R, Vera R, Ramón Y Cajal S, Hernández-Losa J, Landolfi S, Musulén E, Cuatrecasas M, Navarro |
|
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Clinical colorectal cancer 2020 Mar . Sastre Javier, Orden Virginia de la, Martínez Antonio, Bando Inmaculada, Balbín Milagros, Bellosillo Beatriz, Palanca Sarai, Peligros Gomez Maria Isabel, Mediero Beatriz, Llovet Patricia, Moral Virginia Moreno, Viéitez José Maria, García-Alfonso Pilar, Calle Silvia Gil, Ortiz-Morales Maria José, Salud Antonieta, Quintero Guillermo, Lopez Carlos, Díaz-Rubio Eduardo, Aranda Enrique, |
|
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.
Clinical colorectal cancer 2020 Mar . Kasper Stefan, Meiler Johannes, Knipp Heike, Höhler Thomas, Reimer Peter, Steinmetz Tilman, Berger Winfried, Linden Gabriele, Reis Henning, Markus Peter, Paul Andreas, Dechêne Alexander, Schumacher Brigitte, Kostbade Karina, Virchow Isabel, Ting Saskia, Worm Karl, Schmid Kurt W, Herold Thomas, Wiesweg Marcel, Schuler Martin, Trarbach Tan |
|
Imaging predictors of BRAF mutation in colorectal cancer.
Abdominal radiology (New York) 2020 Mar . Eurboonyanun Kulyada, Lahoud Rita Maria, Kordbacheh Hamed, Pourvaziri Ali, Promsorn Julaluck, Chadbunchachai Payia, O'Shea Aileen, Atre Isha D, Harisinghani Muke |
|
RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
Oncology reports 2020 Mar . Matsumoto Akio, Shimada Yoshifumi, Nakano Mae, Oyanagi Hidehito, Tajima Yosuke, Nakano Masato, Kameyama Hitoshi, Hirose Yuki, Ichikawa Hiroshi, Nagahashi Masayuki, Nogami Hitoshi, Maruyama Satoshi, Takii Yasumasa, Ling Yiwei, Okuda Shujiro, Wakai Toshifu |
|
Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways.
British journal of cancer 2020 Mar . Amitay Efrat L, Carr Prudence R, Jansen Lina, Roth Wilfried, Alwers Elizabeth, Herpel Esther, Kloor Matthias, Bläker Hendrik, Chang-Claude Jenny, Brenner Hermann, Hoffmeister Micha |
|
Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
Gastroenterology 2020 Feb . Phipps Amanda I, Alwers Elizabeth, Harrison Tabitha, Banbury Barbara, Brenner Hermann, Campbell Peter T, Chang-Claude Jenny, Buchanan Daniel, Chan Andrew T, Farris Alton B, Figueiredo Jane C, Gallinger Steven, Giles Graham G, Jenkins Mark, Milne Roger L, Newcomb Polly A, Slattery Martha L, Song Mingyang, Ogino Shuji, Zaidi Syed H, Hoffmeister Michael, Peters Ulri |
|
RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
Pathology, research and practice 2020 Feb 152898. Ta To Van, Nguyen Quang Ngoc, Chu Ha Hoang, Truong Van-Long, Vuong Linh Di |
|
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.
Frontiers in oncology 2020 10 568911. Xu Ting, Zhang Yinjie, Zhang Jing, Qi Changsong, Liu Dan, Wang Zhenghang, Li Yanyan, Ji Congcong, Li Jian, Lin Xuan, Hou Ting, Liu Hao, Zhang Lu, Han-Zhang Han, Shen Lin, Wang Xiche |
|
KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.
PloS one 2020 15 (7): e0235490. Sanchez-Ibarra Hector Eduardo, Jiang Xianli, Gallegos-Gonzalez Elena Yareli, Cavazos-González Adriana Carolina, Chen Yenho, Morcos Faruck, Barrera-Saldaña Hugo Alber |
|
Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum.
PloS one 2020 15 (2): e0229262. Nakanishi Hiroyoshi, Sawada Takeshi, Kaizaki Yasuharu, Ota Ryosuke, Suzuki Hiromu, Yamamoto Eiichiro, Aoki Hironori, Eizuka Makoto, Hasatani Kenkei, Takahashi Naoki, Inagaki Satoko, Ebi Masahide, Kato Hiroyuki, Kubota Eiji, Kataoka Hiromi, Takahashi Satoru, Tokino Takashi, Minamoto Toshinari, Sugai Tamotsu, Sasaki Yasus |
|
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer.
JCO precision oncology 2019 3 . Johnson Benny, Loree Jonathan M, Jacome Alexandre A, Mendis Shehara, Syed Muddassir, Morris Ii Van K, Parseghian Christine M, Dasari Arvind, Pant Shubham, Raymond Victoria M, Vilar Eduardo, Overman Michael, Kee Bryan, Eng Cathy, Raghav Kanwal, Kopetz Sco |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 27, 2020
- Content source: